Healthy Living/WellnessStudies Say Merck Antibody Cuts Risks Of Clostridium Difficile Recurrence Merck’s bezlotoxumab has been found by two Phase 3 studies to be effective in reducing risks of recurrence involving Clostridium difficile infections.by Dianne Depra
Healthy Living/WellnessCalifornia Launches Online Tool To Help Consumers Compare Healthcare Quality And Costsby Katrina Pascual
Healthy Living/WellnessScientists Grow Human Sperm In Lab: Cure For Infertility Or Not?by Katrina Pascual
Healthy Living/WellnessDispose Of Expired Medications Properly, Turn Them In On National Drug Take Back Dayby Katrina Pascual
Healthy Living/Wellness$13.50 To $750: Price Of Popular Parasitic Infection Drug Daraprim Increases By About 5,000 Percentby Rhodi Lee
Healthy Living/WellnessNo Beard, No Problem: Historians Say Era Of Hipster Beard Coming To An Endby Rina Marie Doctor
Healthy Living/WellnessAdolescent Mothers At Higher Risk Of Further Pregnancies During Teenage Years: Studyby Rina Marie Doctor
Healthy Living/WellnessDrug Used To Treat Arthritis May Be Effective Against Alzheimer's Disease Symptomsby Rina Marie Doctor
Healthy Living/WellnessHigh Cost Drives Some Medical Marijuana Patients in Minnesota to Buy Pot Illegallyby Katrina Pascual
Healthy Living/WellnessParents Can Help Their Bulimic Kids Recover Faster: Here's Howby Katherine Derla
Healthy Living/WellnessNutritionist Says Homemade Baby Food Helps Set Up Lifetime Of Healthy Eatingby Julienne Roman